- Report
- June 2023
- 338 Pages
Global
From €7206EUR$7,500USD£6,197GBP
Zioptan is a brand of ophthalmic solution used to treat certain types of eye disorders, such as glaucoma and ocular hypertension. It is a prostaglandin analog, which works by reducing the pressure inside the eye. It is available in the form of eye drops and is administered once daily. Zioptan is manufactured by Bausch + Lomb, a leading global eye health company.
The Zioptan market is a segment of the larger Optical Disorders Drugs market, which includes a range of treatments for various eye conditions. These treatments include medications, laser treatments, and surgical procedures. The Optical Disorders Drugs market is expected to grow in the coming years, driven by an aging population and increasing prevalence of eye diseases.
Some of the major companies in the Zioptan market include Bausch + Lomb, Allergan, Novartis, Pfizer, and Merck. These companies are engaged in the development, manufacture, and marketing of Zioptan and other ophthalmic solutions. Show Less Read more